Allavena C - Search Results

1

VIH et vieillissement, de nouveaux défis pour la recherche clinique.

Allavena C. Allavena C. Soins. 2019 Apr;64(834):54. doi: 10.1016/j.soin.2019.02.013. Soins. 2019. PMID: 31023472 Free article. French. No abstract available.

2

Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapy.

Allavena C, Rodallec A, Leplat A, Hall N, Luco C, Le Guen L, Bernaud C, Bouchez S, André-Garnier E, Boutoille D, Ferré V, Raffi F. Allavena C, et al. J Virol Methods. 2018 Jan;251:106-110. doi: 10.1016/j.jviromet.2017.10.016. Epub 2017 Oct 16. J Virol Methods. 2018. PMID: 29042218

3

Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).

Allavena C, Volteau C, André-Garnier E, Guimard T, Hall N, Khatchatourian L, Morrier M, Billaud E, Rodallec A, Reliquet V, Jovelin T, Le Guen L, Perré P, Grégoire M, Raffi F. Allavena C, et al. Med Mal Infect. 2019 Oct;49(7):505-510. doi: 10.1016/j.medmal.2018.11.012. Epub 2018 Dec 21. Med Mal Infect. 2019. PMID: 30583867

4

High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.

Allavena C, Delpierre C, Cuzin L, Rey D, Viget N, Bernard J, Guillot P, Duvivier C, Billaud E, Raffi F. Allavena C, et al. J Antimicrob Chemother. 2012 Sep;67(9):2222-30. doi: 10.1093/jac/dks176. Epub 2012 May 15. J Antimicrob Chemother. 2012. PMID: 22589455

5

Tipranavir in highly antiretroviral treatment-experienced patients: Results from a French prospective cohort.

Allavena C, Flandre P, Pugliese P, Valantin MA, Poizot-Martin I, Cabié A, Melliez H, Cuzin L, Duvivier C, Dellamonica P, Raffi F; Dat'aids Group. Allavena C, et al. Scand J Infect Dis. 2012 Jan;44(1):37-43. doi: 10.3109/00365548.2011.598870. Epub 2011 Aug 19. Scand J Infect Dis. 2012. PMID: 21851330

6

Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.

Allavena C, Bach-Ngohou K, Billaud E, Sécher S, Dejoie T, Reliquet V, Fakhouri F, Raffi F. Allavena C, et al. J Antimicrob Chemother. 2013 Dec;68(12):2866-70. doi: 10.1093/jac/dkt265. Epub 2013 Jun 30. J Antimicrob Chemother. 2013. PMID: 23818285

7

Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen.

Allavena C, Rodallec A, Sécher S, Reliquet V, Baffoin S, André-Garnier E, Billaud E, Raffi F, Ferré V. Allavena C, et al. J Med Virol. 2013 Nov;85(11):1878-82. doi: 10.1002/jmv.23679. Epub 2013 Jul 16. J Med Virol. 2013. PMID: 23861166

8

Polypharmacy and risk of admission to hospital in people ageing with HIV: what is the contribution of drug-drug interactions?

Allavena C, Marzolini C. Allavena C, et al. Lancet Healthy Longev. 2021 Oct;2(10):e606-e607. doi: 10.1016/S2666-7568(21)00227-0. Epub 2021 Sep 29. Lancet Healthy Longev. 2021. PMID: 36098012 Free article. No abstract available.

9

Sport and self-esteem in people living with HIV: a cross-sectional study.

Grandiere Perez L, Allavena C, Sécher S, Durand S, Grégoire A, Vandamme YM, Hitoto H, Leautez-Nainville S, Michau C, Billaud E. Grandiere Perez L, et al. Among authors: allavena c. BMC Infect Dis. 2022 Nov 17;22(1):858. doi: 10.1186/s12879-022-07860-y. BMC Infect Dis. 2022. PMID: 36396982 Free PMC article.

10

Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.

Lewden C, Raffi F, Cuzin L, Cailleton V, Vildé JL, Chêne G, Allavena C, Salamon R, Leport C. Lewden C, et al. Among authors: allavena c. J Infect Dis. 2002 Sep 1;186(5):710-4. doi: 10.1086/342047. Epub 2002 Jul 29. J Infect Dis. 2002. PMID: 12195361 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters